Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Nov;14(5):1228–1240. doi: 10.1128/iai.14.5.1228-1240.1976

Persistence, pathogenesis, and morphology of an L-form of Streptococcus pyogenes adapted to physiological isotonic conditions when in immunosuppressed mice.

P B Fernandes, C Panos
PMCID: PMC415518  PMID: 789243

Abstract

Evidence obtained using nonimmunosuppressed and newborn mice suggests that the immune response of the host plays a role in the rapid removal of a physiologically isotonic L-form of Streptococcus pyogenes, since its inability to persist in vivo was not due to osmotic lysis. With mice immunosuppressed with methylprednisolone sodium succinate, viability and detection of this L-form by fluorescent antibody was prolonged for at least 2 weeks, the approximate duration of immunosuppression in these mice. However, heat-killed L-form cells only persisted for 3 days in such mice. Therefore, persistence of a viable L-form in these treated mice was not simply due to the lack of removal of L-forms by a compromised host. At no time was there any indication of illness in nonimmunosuppressed or immunosuppressed mice after L-form injection, and all internal organs, when examined macroscopically, remained normal. Thus, overt pathogenesis was not a characteristic of this L-form in a suitable host even when its immune response had been compromised. The microscopic morphology of the L-form after isolation from immunosuppressed mice changed drastically. It was typically micrococcal in appearance and exemplified the cellular variability achievable by this organism in vivo. Also, streptolysin S production was increased markedly by passage of the L-form in immunosuppressed mice. However, M protein, as a cellular component, was not detected serologically, nor was any reformation of a rigid cell wall apparent by electron microscopy after isolation of this streptococcal L-form from such mice.

Full text

PDF
1231

Images in this article

1232Image
on p.1232
1233Image
on p.1233
1234Image
on p.1234
1235Image
on p.1235
1236Image
on p.1236
1237Image
on p.1237

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chevion M., Panos C., Paxton J. Membrane studies of Streptococcus pyogenes and its L-form growing in hypertonic and physiologically isotonic media. An electron spin resonance spectroscopy approach. Biochim Biophys Acta. 1976 Mar 5;426(2):288–301. doi: 10.1016/0005-2736(76)90338-2. [DOI] [PubMed] [Google Scholar]
  2. Clasener H. A., Ensering H. L., Hijmans W. Persistance in mice of the L-phase of three streptococcal strains adapted to physiological osmotic conditions. J Gen Microbiol. 1970 Aug;62(2):195–202. doi: 10.1099/00221287-62-2-195. [DOI] [PubMed] [Google Scholar]
  3. Cohen J. O., Pine L. Quantitative aspects of the M protein capillary precipitin test. Appl Microbiol. 1968 Jan;16(1):122–127. doi: 10.1128/am.16.1.122-127.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cunningham A. J., Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 1968 Apr;14(4):599–600. [PMC free article] [PubMed] [Google Scholar]
  5. DENNY F. W., Jr, THOMAS L. Persistence of group A streptococci in tissues of rabbits after infection. Proc Soc Exp Biol Med. 1955 Feb;88(2):260–263. doi: 10.3181/00379727-88-21557. [DOI] [PubMed] [Google Scholar]
  6. DIENES L., WEINBERGER H. J. The L forms of bacteria. Bacteriol Rev. 1951 Dec;15(4):245–288. doi: 10.1128/br.15.4.245-288.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  8. GLASER R. J., BERRY J. W., LOEB L. H., WOOD W. B., Jr The effect of cortisone in streptococcal lymphadenitis and pneumonia. J Lab Clin Med. 1951 Sep;38(3):363–373. [PubMed] [Google Scholar]
  9. Ginsburg I. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J Infect Dis. 1972 Sep;126(3):294–340. doi: 10.1093/infdis/126.3.294. [DOI] [PubMed] [Google Scholar]
  10. HAROLD F. M. STABILIZATION OF STREPTOCOCCUS FAECALIS PROTOPLASTS BY SPERMINE. J Bacteriol. 1964 Nov;88:1416–1420. doi: 10.1128/jb.88.5.1416-1420.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KASS E. H., FINLAND M. Corticosteroids and infections. Adv Intern Med. 1958;9:45–80. [PubMed] [Google Scholar]
  12. LEEDOM J. M., BARKULIS S. S. Studies on virulence of group A beta-hemolytic streptococci. J Bacteriol. 1959 Nov;78:687–694. doi: 10.1128/jb.78.5.687-694.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Leon O., Panos C. Adaptation of an osmotically fragile L-form of Streptococcus pyogenes to physiological osmotic conditions and its ability to destroy human heart cells in tissue culture. Infect Immun. 1976 Jan;13(1):252–262. doi: 10.1128/iai.13.1.252-262.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGee Z. A., Ratner H. B., Bryant R. E., Rosenthal A. S., Koenig M. G. An antibody-complement system in human serum lethal to L-phase variants of bacteria. J Infect Dis. 1972 Mar;125(3):231–242. doi: 10.1093/infdis/125.3.231. [DOI] [PubMed] [Google Scholar]
  16. Muschel L. H., Jackson J. E. The reactivity of serum against protoplasts and spheroplasts. J Immunol. 1966 Jul;97(1):46–51. [PubMed] [Google Scholar]
  17. NICHOLS R. L., McCOMB D. E. Immunofluorescent studies with trachoma and related antigens. J Immunol. 1962 Oct;89:545–554. [PubMed] [Google Scholar]
  18. RINDERKNECHT H. Ultra-rapid fluorescent labelling of proteins. Nature. 1962 Jan 13;193:167–168. doi: 10.1038/193167b0. [DOI] [PubMed] [Google Scholar]
  19. Rickles N., Zilberstein Z., Kraus S., Arad G., Kaufstein M., Ginsburg I. Persistence of group A streptococci labeled with fluorescein isothiocyanate in inflammatory sites in the heart and muscle of mice and rabbits. Proc Soc Exp Biol Med. 1969 Jun;131(2):525–530. doi: 10.3181/00379727-131-33917. [DOI] [PubMed] [Google Scholar]
  20. Schmitt-Slomska J., Sacquet E., Caravano R. Group A streptococcal L forms. I. Persistence among inoculated mice. J Bacteriol. 1967 Jan;93(1):451–455. doi: 10.1128/jb.93.1.451-455.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. WEISSMANN G., BECHER B., THOMAS L. STUDIES ON LYSOSOMES. V. THE EFFECTS OF STREPTOLYSINS AND OTHER HEMOLYTIC AGENTS ON ISOLATED LEUCOCYTE GRANULES. J Cell Biol. 1964 Jul;22:115–126. doi: 10.1083/jcb.22.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WEISSMANN G., KEISER H., BERNHEIMER A. W. STUDIES ON LYSOSOMES. III. THE EFFECTS OF STREPTOLYSINS O AND S ON THE RELEASE OF ACID HYDROLASES FROM A GRANULAR FRACTION OF RABBIT LIVER. J Exp Med. 1963 Aug 1;118:205–222. doi: 10.1084/jem.118.2.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Webster A. D., Hall G. H. Acute post-streptococcal toxaemic renal failure. Br Med J. 1969 Dec 13;4(5684):665–666. doi: 10.1136/bmj.4.5684.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Winterbauer R. H., Gutman L. T., Turck M., Wedgwood R. J., Petersdorf R. G. The role of penicillin-induced bacterial variants in experimental pyelonephritis. J Exp Med. 1967 Apr 1;125(4):607–618. doi: 10.1084/jem.125.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. YOUNATHAN E. S., BARKULIS S. S. Effect of some antimetabolites on the production of streptolysin S'. J Bacteriol. 1957 Aug;74(2):151–158. doi: 10.1128/jb.74.2.151-158.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES